Kibow Biotech, Inc.  

Newtown Square,  PA 
United States
info@kibowtx.com
https://www.kibowtx.com/
  • Booth: 2729

Kibow is a clinical-stage biotechnology company developing microbiome therapeutics for patients with renal disease. Our lead product, KT-301, is a potential first-in-class oral live biotherapeutic designed to reduce renal and cardiovascular toxins by restoring the microbiome and correcting the dysbiosis observed in patients with CKD. This process is known as "enteric dialysis." KT-301 is an enteric-coated, encapsulated consortium of proprietary strains of commensal bacteria and functional fibers designed to target toxins in the intestine that are linked to renal (urea, uric acid) and cardiovascular (indoxyl sulfate, p-cresyl sulfate, TMAO) diseases. Double-blind, randomized, placebo-controlled Phase 2 clinical trials are underway in approx. 600 CKD Stage IV patients with data expected in 1H2024 (ClinicalTrials.gov Identifiers: NCT04913272 and NCT05407389). Kibow has been a leader for over 20 years in developing microbiome therapeutics and their potential positive impacts on renal disease. RENADYL has been successfully marketed for several years as a dietary supplement for maintaining kidney health, and we have an exclusive animal health partner marketing AZODYL for veterinary use.


 Promotional Flyers


 Products

  • Renadyl™– A Pro/Prebiotic Kidney Health Supplement
    Renadyl™– A Probiotic and Prebiotic Natural Kidney Health Supplement...

  • Renadyl™ is an oral proprietary dietary supplement that has been scientifically formulated and clinically tested to reduce nitrogenous waste metabolites in the bowel and stabilize healthy gut flora.

    Our probiotic formulation of S.thermophilus (KB 19), L.acidophilus (KB27), and B.longum (KB31) are naturally occurring microbes that target and metabolize various nitrogenous wastes that diffuse from the blood-stream into the bowel. These beneficial microbes have a high affinity for metabolizing and consuming the targeted nitrogenous waste products.  

    Renadyl™ also contains Inulin and Xylo-oligosaccharides, which are considered prebiotic or fiber components. Generally, prebiotic components such as Inulin and Xylo-oligosaccharides are indigestible until they reach the bowel where it is used as food for the trillions of microbes present in the large bowel. Hence, prebiotics are often used as a source of dietary fiber and are widely used in all dietary supplements. Dietary fibers are often beneficial for promoting additional good bacteria in the large bowel.

    The nitrogenous waste products targeted by Renadyl's formulation include several metabolites. Some of these are urea, uric acid, creatinine, indoles, phenols, nitrosamines, and several other nitrogenous waste products.*

  • Kibow Fortis®
    Kibow Fortis® is a prebiotic multi-fiber dietary supplement consisting of soluble and insoluble fibers for overall wellness applications, with daily fiber augmentation for unique general wellness benefits....

  • Kibow Fortis® is a highly effective prebiotic dietary supplement made with 7-Functional Fibers. This blend of prebiotics is known for its cholesterol-reducing properties, promoting satiety or a feeling of fullness and a boost in the immune systems. Kibow Fortis® consists of soluble and insoluble fibers providing unique general wellness benefits. This formulation provides an optimum environment for a healthy balance of good bacteria in the intestinal flora matrix


 Additional Info

First-time Exhibitor:
No